share_log

Stephens & Co. Reiterates Equal-Weight on Lifecore Biomedical, Maintains $6 Price Target

Benzinga ·  Jan 3 14:08  · Ratings

Stephens & Co. analyst Jacob Johnson reiterates Lifecore Biomedical (NASDAQ:LFCR) with a Equal-Weight and maintains $6 price target.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Comment Comment · Views 217

Recommended

Write a comment